Literature DB >> 18542932

Orthostatic hypotensive effect of antipsychotic drugs in Wistar rats by in vivo and in vitro studies of alpha1-adrenoceptor function.

Z Nourian1, T Mow, D Muftic, S Burek, M L Pedersen, J Matz, M J Mulvany.   

Abstract

RATIONALE: Many antipsychotics cause orthostatic hypotension possibly due to antagonist action on resistance vessel alpha1A-adrenoceptors (alpha1A-AR).
OBJECTIVE: We have tested this possibility by determining in Wistar rats how the orthostatic hypotensive effect of several antipsychotic drugs compares with their affinity for adrenoceptors in mesenteric small arteries (MSA with mainly alpha1A-AR) and aorta (mainly alpha1D-AR).
MATERIALS AND METHODS: Using a tilt setup, orthostatic hypotension was measured in anaesthetized rats for prazosin and the antipsychotics haloperidol, sertindole, risperidone, clozapine, ziprasidone, domperidone, olanzapine, and aripiprazole. For in vitro studies, segments of MSA and aorta were mounted on a wire myograph for isometric tension recording. Cumulative concentration-response curves were constructed to phenylephrine (PE) in the absence and presence of the drugs. Apparent affinity (pA2) was calculated by Schild analysis.
RESULTS: Prazosin antagonized tilt-induced and PE responses in both studies (threshold 4 ng/ml, pA2 9.52 MSA, 10.1 aorta). The rank order of the potency of the antipsychotics in the tilt experiments correlated (r2 = 0.69, P = 0.01) with the pA2-values in MSA: Risperidone and sertindole had the highest potency in the tilt test (threshold 159 and 97 ng/ml) and the highest apparent affinity in MSA (pA2 8.92 and 8.78), in contrast with aripiprazole and domperidone, which had the lowest in each case (threshold 4.1 and 3.0 microg/ml, pA2 7.17 and 6.99). In aorta, the pA2 values did not correlate with the in vivo potencies; in particular, sertindole had no functional affinity in aorta.
CONCLUSION: We conclude that the orthostatic hypotensive effect in rats of the antipsychotic drugs investigated is mediated through alpha1A-ARs.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18542932     DOI: 10.1007/s00213-007-1064-9

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  52 in total

1.  Risperidone compared with new and reference antipsychotic drugs: in vitro and in vivo receptor binding.

Authors:  A Schotte; P F Janssen; W Gommeren; W H Luyten; P Van Gompel; A S Lesage; K De Loore; J E Leysen
Journal:  Psychopharmacology (Berl)       Date:  1996-03       Impact factor: 4.530

2.  Two rapid-dose titrations of sertindole in patients with schizophrenia.

Authors:  J J Sramek; R J Mack; W Awni; J Hourani; S S Jhee; S Barto; N R Cutler
Journal:  J Clin Psychopharmacol       Date:  1997-10       Impact factor: 3.153

3.  Characterization of alpha1-adrenoceptor subtypes mediating contractions to phenylephrine in rat thoracic aorta, mesenteric artery and pulmonary artery.

Authors:  M B Hussain; I Marshall
Journal:  Br J Pharmacol       Date:  1997-11       Impact factor: 8.739

Review 4.  Tolerability of atypical antipsychotics.

Authors:  C Stanniland; D Taylor
Journal:  Drug Saf       Date:  2000-03       Impact factor: 5.606

5.  Mesenteric blood pressure profile of conscious, freely moving rats.

Authors:  J Fenger-Gron; M J Mulvany; K L Christensen
Journal:  J Physiol       Date:  1995-11-01       Impact factor: 5.182

6.  Ziprasidone: a novel antipsychotic agent with a unique human receptor binding profile.

Authors:  A W Schmidt; L A Lebel; H R Howard; S H Zorn
Journal:  Eur J Pharmacol       Date:  2001-08-17       Impact factor: 4.432

Review 7.  The relationship of pharmacology to side effects.

Authors:  D E Casey
Journal:  J Clin Psychiatry       Date:  1997       Impact factor: 4.384

Review 8.  Side effect profiles of new antipsychotic agents.

Authors:  D E Casey
Journal:  J Clin Psychiatry       Date:  1996       Impact factor: 4.384

9.  Some quantitative uses of drug antagonists.

Authors:  O ARUNLAKSHANA; H O SCHILD
Journal:  Br J Pharmacol Chemother       Date:  1959-03

10.  Postural hypotension in chronically medicated schizophrenics.

Authors:  H Silver; H Kogan; D Zlotogorski
Journal:  J Clin Psychiatry       Date:  1990-11       Impact factor: 4.384

View more
  6 in total

1.  Prolonged bed rest impairs rapid CPI-17 phosphorylation and contraction in rat mesenteric resistance arteries to cause orthostatic hypotension.

Authors:  Toshio Kitazawa; Kazuyo Kitazawa
Journal:  Pflugers Arch       Date:  2017-07-17       Impact factor: 3.657

Review 2.  Updates in the function and regulation of α1 -adrenoceptors.

Authors:  Juliana Akinaga; J Adolfo García-Sáinz; André S Pupo
Journal:  Br J Pharmacol       Date:  2019-04-01       Impact factor: 8.739

3.  The affinity and selectivity of α-adrenoceptor antagonists, antidepressants, and antipsychotics for the human α1A, α1B, and α1D-adrenoceptors.

Authors:  Richard G W Proudman; Andre S Pupo; Jillian G Baker
Journal:  Pharmacol Res Perspect       Date:  2020-08

4.  Anti-hypotensive effect of "Yahom Navakot" in rats with orthostatic hypotension.

Authors:  Anjaree Inchan; Thanika Pathomwichaiwat; Tippaporn Bualeong; Sasipong Tipratchadaporn; Krongkarn Chootip
Journal:  J Tradit Complement Med       Date:  2021-08-03

5.  Olanzapine-induced Orthostatic Hypotension.

Authors:  Amlan Kusum Jana; Samir Kumar Praharaj; Nirmalya Roy
Journal:  Clin Psychopharmacol Neurosci       Date:  2015-04-30       Impact factor: 2.582

Review 6.  Safety, tolerability, and risks associated with first- and second-generation antipsychotics: a state-of-the-art clinical review.

Authors:  Marco Solmi; Andrea Murru; Isabella Pacchiarotti; Juan Undurraga; Nicola Veronese; Michele Fornaro; Brendon Stubbs; Francesco Monaco; Eduard Vieta; Mary V Seeman; Christoph U Correll; André F Carvalho
Journal:  Ther Clin Risk Manag       Date:  2017-06-29       Impact factor: 2.423

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.